GOOD NEWS: For Some Breast Cancer Patients, The Chemo Decision Just Got Easier. “A study published Sunday finds that many women with early-stage invasive breast cancer could safely forgo chemotherapy, if they score in the midrange or lower for risk that their cancer will recur, as measured by a commonly used genomic test.”